Precigen Inc (NAS:PGEN)
$ 1.65 0.09 (5.77%) Market Cap: 416.49 Mil Enterprise Value: 355.72 Mil PE Ratio: 0 PB Ratio: 4.23 GF Score: 42/100

Precigen Inc at JPMorgan Healthcare Conference Transcript

Jan 11, 2024 / 01:15AM GMT
Release Date Price: $1.38 (+2.22%)
Brain Cheng JPMorgan Chase;Co.;Analyst

&-

Good afternoon and thanks for joining us for another session at the 42nd JPMorgan Healthcare Conference. I'm Brian Cheng. I'm one of the senior biotech analysts here. I'm joined by my associate, John Kim, who's in the audience. On stage, we have President and CEO, I'll pass the mike to Helen for a short presentation, followed by a Q&A either joining us live we can submit questions through the conference portal and if you're first joining us virtually and you can also submit a question as well online. Helen the stage is yours.

Helen Sabzevari Precigen
Inc. - President & CEO

Thank you very much Brian. Thank you -for having us here, at JPMorgan this year. First of all, I may obviously would be making some forward-looking statements. So please make sure that you look at this slide in detail. With that, what I would like to be start with and about Precigen and what a transformative year we are going to have in front of us.

I think we are very excited about the strategy of Precigen,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot